Fig. 2From: Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cellsFT-IR characterization of a m-HAP, b neat 6-gingerol, c 6-Gin-m-HAP, d neat doxorubicin, e Dox-m-HAP, f 6-Gin + Dox-m-HAPBack to article page